Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
Stopped early · Phase 2 · Has a placebo group
Conditions studied: Pruritus, Burns
In brief
Study of the Efficacy, Safety \& Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
Key facts
- Study ID
- NCT02975271
- Run by
- Vyne Therapeutics Inc.
- People needed
- 1
- Starts
- 2016-11-01
- Expected to finish
- 2017-01-17
- Last updated by the study team
- 2021-05-20
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Study Site 404 — Phoenix, Arizona, United States
- Study Site 402 — Washington D.C., District of Columbia, United States
- Study Site 412 — Gainesville, Florida, United States
- Study Site 403 — Tampa, Florida, United States
- Study Site 409 — Lincoln, Nebraska, United States
- Study Site 401 — Winston-Salem, North Carolina, United States
- Study Site 413 — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.